Cara Therapeutics (CARA) EV/EBITDA US GAAP (year values)

2020 2021 2022 2023 2023   LTM ?
EV/EBITDA ? 96.8 -5.15 -5.16 0.14 0.15   -0.29
Changes by years, y/y, % -2 111% -105% +0% -103% +3%    

Cara Therapeutics. EV/EBITDA

Cara Therapeutics. EV/EBITDA, changes, %

Cara Therapeutics (CARA) EV/EBITDA US GAAP (quarter values)

2023Q4 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EV/EBITDA ? 0.14 0.15 -0.21 0.33 0.24   -0.29
Changes by years, y/y, % -103% -103% -88% -163% -246%    
Changes by quarters, q/q, % -185% +4% -243% -255% -25%    

Cara Therapeutics. EV/EBITDA

Cara Therapeutics. EV/EBITDA, changes, y/y, %

Cara Therapeutics. EV/EBITDA, changes, q/q, %